We stained the tumor tissue sections with five markers, α-SMA, GLUT1, CD68, ICAM1, and GPNMB, to exclude the possibility of simultaneous expression of ICAM1 and GPNMB by the same MDMs. The gene discussed is SLC2A1; the disease is neoplasm.